Digitalis Investigation Group (DIG) trial: a stimulus for further research.
Gheorghiade
M
M
Department of Medicine, Northwestern University Medical School, Chicago, Ill. 60611, USA.
Pitt
B
B
D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D002423:Cause of Death; D016757:Death, Sudden, Cardiac / Q000209:etiology; D004071:Digitalis Glycosides / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D018450:Disease Progression; D004232:Diuretics / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006339:Heart Rate; D006760:Hospitalization; D006801:Humans; D008297:Male; D010919:Placebos; D016032:Randomized Controlled Trials as Topic; D012106:Research; D013318:Stroke Volume; D016896:Treatment Outcome; D016277:Ventricular Function, Left
D000806:Angiotensin-Converting Enzyme Inhibitors; D002316:Cardiotonic Agents; D004071:Digitalis Glycosides; D004232:Diuretics; D004338:Drug Combinations; D010919:Placebos